Concepedia

Author

Melanie Quintana

Berry & Associates (United States)ORCID

Also Known As

Anna McGlothlin, Giorgio Paulon, M Quintana, M. Quintana, Melanie Quintana, Melanie Shantal Noboa Quintana, Melanie W. Quintana, Quintana, Melanie

48

Publications

1.4K

Citations

16

H-Index

32

Concepts

All Affiliations

Berry & Associates (United States)Massachusetts General HospitalUniversity of Kansas Medical CenterHarvard UniversityWashington University in St. Louis
MQ

About

Melanie Quintana is an author at Berry & Associates (United States) specializing in medicine, public health, and biostatistics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

188

2

Public Health

2

2

49

3

Biostatistics

2

2

44

4

Cellular Therapies

1

1

11

5

Epidemiology

1

1

16

Melanie Quintana

×

14

Publications

718

Citations

12

H-Index

YearCitations

The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model

Randall J. Bateman, Tammie L.S. Benzinger, Scott Berry,

Alzheimer s & Dementia

2016

287

Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Adam M. Staffaroni, Melanie Quintana, Barbara Wendelberger,

Nature Medicine

2022

128

A novel cognitive disease progression model for clinical trials in autosomal‐dominant Alzheimer's disease

Guoqiao Wang, Scott Berry, Chengjie Xiong,

Statistics in Medicine

2018

62

Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study

Nuria Carrillo, May Christine V. Malicdan, Petcharat Leoyklang,

Genetics in Medicine

2021

52

Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis

Melanie Quintana, Benjamin R. Saville, Matteo Vestrucci,

Annals of Neurology

2023

33

A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization

Alexandra R. Brown, Byron J. Gajewski, Lauren S. Aaronson,

Trials

2016

26

Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot

Byron J. Gajewski, Scott Berry, Melanie Quintana,

Statistics in Medicine

2015

25

Bayesian model of disease progression in GNE myopathy

Melanie Quintana, Joseph A. Shrader, Christina Slota,

Statistics in Medicine

2018

24

Strategies to Promote ResiliencY (SPRY): a randomised embedded multifactorial adaptative platform (REMAP) clinical trial protocol to study interventions to improve recovery after surgery in high-risk patients

Katherine M. Reitz, Christopher Seymour, Jennifer Vates,

BMJ Open

2020

17

Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1b

Phil McEwan, Thomas Ward, Samantha Webster,

Value in Health Regional Issues

2014

16

Page 1